[Lecture Report] The 7th NIKKEI FT Communicable Diseases Conference – Strategies for Coexisting with Communicable Diseases: Japanese PPP Initiative through Technological Innovation- (The NIKKEI, November 6-7, 2020, Yokohama City, Kanagawa Prefecture)
date : 11/27/2020
![[Lecture Report] The 7th NIKKEI FT Communicable Diseases Conference – Strategies for Coexisting with Communicable Diseases: Japanese PPP Initiative through Technological Innovation- (The NIKKEI, November 6-7, 2020, Yokohama City, Kanagawa Prefecture)](https://hgpi.org/en/wp-content/uploads/sites/2/110607-top.jpg)
On November 6 and 7, 2020, HGPI Chairman Dr. Kiyoshi Kurokawa and HGPI CEO and Board Member Mr. Ryoji Noritake spoke at various programs throughout both days of the 7th NIKKEI FT Communicable Diseases Conference, which was entitled “Strategies for Coexisting with Communicable Diseases: Japanese PPP Initiative through Technological Innovation.” The event was co-hosted by the NIKKEI and the Financial Times.
For details, please visit the event website, which can be found here.
Below is an excerpt from the program that included Dr. Kurokawa and Mr. Noritake. The full speaker list can be viewed here.
Friday, November 6, 2020
Lunch Session- BD Japan: The role of testing in communicable diseases～Learning from COVID-19
Moderator: Ryoji Noritake (HGPI Board Member and CEO)
Breakout Session A-1: Challenges and Efforts to Address the Threat of Infectious Diseases – Learning from the Cases of AMR and COVID-19
Discusser: Ryoji Noritake (HGPI Board Member and CEO)
Breakout Session A-2: Challenges and Efforts to Address the Threat of Infectious Diseases – Learning from the Cases of AMR and COVID-19
Discusser: Ryoji Noritake (HGPI Board Member and CEO)
Saturday, November 7, 2020
Keynote Session- Dr. Yasuhiro Suzuki, Former Vice-Minister for Health／Chief Medical & Global Health Officer, MHLW, Japan
Discusser: Kiyoshi Kurokawa (HGPI Chairman)
Special Session III: Speeches from Governors
Moderator: Ryoji Noritake (HGPI Board Member and CEO)
Special Session III: Speeches from Governors
Moderator: Ryoji Noritake (HGPI Board Member and CEO)
Agenda6- Coexisting with COVID-19 ～The Role of Japanese Initiatives
Moderator: Ryoji Noritake (HGPI Board Member and CEO)
Discusser: Kiyoshi Kurokawa (HGPI Chairman)
Summary Session
Discusser: Ryoji Noritake (HGPI Board Member and CEO)
Conclusion/Statement
Discusser: Ryoji Noritake (HGPI Board Member and CEO)
Top Research & Recommendations Posts
- [Research Report] Energy Conservation and Greenhouse Gas Emissions Reduction in Healthcare Facilities: Case Studies from New Construction and Facility Renewal (March 16, 2026)
- [Research Report] Perceptions, Knowledge, Actions and Perspectives of Healthcare Organizations in Japan in Relation to Climate Change and Health: A Cross-Sectional Study (November 13, 2025)
- [Public Comment Submission] “The 7th Science, Technology and Innovation Basic Plan” (Draft) (February 19, 2026)
- [Policy Recommendations] Dementia Project “The Future of Dementia Policy Surrounding Families and Others Who Care for People with Dementia” (April 27, 2026)
- [Research Report] The 2025 Public Opinion Survey on Healthcare in Japan (March 17, 2025)
- [Policy Recommendations] Mental Health Project: Recommendations on Three Issues in the Area of Mental Health (July 4, 2025)
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Research Report] The 2026 Public Opinion Survey on Healthcare in Japan (February 13, 2026)
- [Research Report] A Nationwide Survey on Cancer in Japan: 20 Years Since the Enactment of the Cancer Control Act (April 28, 2026)
- [Research Report] AMR Policy Update #2: WHO’s First Report on Fungal Infection—Bridging the Gap Between Clinical Practice and R&D
Featured Posts
-
2026-05-13
[Registration Open] HGPI Salon 2025-2026 Looking Ahead to the Future of Japan’s Social Security System “Session 5: The Value of Healthcare in Society – Perspectives from the Reiwa Era” (June 29, 2026)
![[Registration Open] HGPI Salon 2025-2026 Looking Ahead to the Future of Japan’s Social Security System “Session 5: The Value of Healthcare in Society – Perspectives from the Reiwa Era” (June 29, 2026)](https://hgpi.org/en/wp-content/uploads/sites/2/5thHGPISalon_20260629.png)
-
2026-05-15
[Registration Open] (Webinar) The 2nd J-PEP Seminar – A New Framework for Providing Information on Clinical Trial Participant Recruitment – Legal Points to Consider from the Perspective of Meaningful Involvement (June 15, 2026)
![[Registration Open] (Webinar) The 2nd J-PEP Seminar – A New Framework for Providing Information on Clinical Trial Participant Recruitment – Legal Points to Consider from the Perspective of Meaningful Involvement (June 15, 2026)](https://hgpi.org/en/wp-content/uploads/sites/2/HGPI_20260615_The2nd-J-PEPseminar.jpg)
-
2026-05-18
[Registration Open] Kick-off Panel Discussion “From Japan and Africa, in Discussion with the World: Cultivating Together a Philosophical Dialogue on Health” (June 15, 2026)
![[Registration Open] Kick-off Panel Discussion “From Japan and Africa, in Discussion with the World: Cultivating Together a Philosophical Dialogue on Health” (June 15, 2026)](https://hgpi.org/en/wp-content/uploads/sites/2/HGPI_20260615_Eyecathch_panel-discussion-From-Japan-and-Africa-in-Discussion-with-the-World‗02.png)
-
2026-05-19
[Registration Open] (Webinar) HGPI Special Seminar “Building a Society Where People Live with Blood Disorders: The Future of Blood Disorder Policy as Examined from the Frontlines of Home-Based Care × Lived Experience Research” (June 12, 2026)
![[Registration Open] (Webinar) HGPI Special Seminar “Building a Society Where People Live with Blood Disorders: The Future of Blood Disorder Policy as Examined from the Frontlines of Home-Based Care × Lived Experience Research” (June 12, 2026)](https://hgpi.org/en/wp-content/uploads/sites/2/HGPI_20260515_HGPI-Special-Seminar-Blood-Disorders.png)
